Statin Therapy

The associations between cardiovascular events and psoriasis have been well documented in peer-reviewed literature. The key question, however, is why do these associations exist?

Healio and Cardiology Today present the most-read cardiology articles for the month of March.

The triglyceride-lowering drug icosapent ethyl reduced stroke incidence in high-risk patients taking statins, according to research presented at the American Stroke Association’s virtual International Stroke Conference.

Antecedent statin therapy conferred improved 30-day in-hospital mortality among patients admitted for COVID-19, despite those patients being older with greater CVD burden compared with those not on statins, researchers reported.

A new study demonstrated a nonlinear inverse relationship between fruit and vegetable consumption and overall mortality. It was the top story in cardiology last week.

Atorvastatin demonstrated no overall effect on the frequency or severity of muscle symptoms among individuals who previously reported severe muscle symptoms while on statins, compared with placebo, according to data published in The BMJ.

Many adults aged at least 75 years are taking aspirin for primary CVD prevention despite lack of evidence, whereas many are not taking statins for primary CVD prevention despite strong evidence, researchers reported.

Older patients with ischemic stroke who took statins for 2 years after discharge experienced fewer CV events after hospital discharge compared with those who took them for less than 2 years or not at all, researchers reported in Stroke.

Statins and placebo triggering symptoms in patients with past statin intolerance.

Statin therapy may have a significant benefit on progression of idiopathic pulmonary fibrosis, according to results of a retrospective study published in Respiratory Medicine.